Scientific publications
Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
Dec 1, 2003
| Magazine: Haematologica
Agirre X, Fontalba A, Andreu EJ, Odero MD, Larráyoz MJ, Montiel C, Calasanz MJ, Fernández-Luna JL, Prósper F
No abstract available
CITA DEL ARTÍCULO Haematologica. 2003 Dec;88(12):1425-6
Our authors
